Navigation Links
Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus

-LymphoStat-B(R) significantly reduced signs and symptoms of SLE disease at 52 Weeks and demonstrated durable clinical and biological activity at 76 weeks-

ROCKVILLE, Md., June 14, 2007 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced the presentation of Phase 2 trial data demonstrating that LymphoStat-B(R) (belimumab) significantly reduced disease activity across multiple clinical measures, was well tolerated and improved quality of life in patients with active systemic lupus erythematosus (SLE). The 52-week and 76-week results of the Phase 2 study were the subject of an oral presentation today in Barcelona at the annual congress of the European League Against Rheumatism (EULAR).

"A number of clinical measures used in the Phase 2 study demonstrate that LymphoStat-B produced significant improvements in disease activity in patients with serologically active SLE," said Ellen Ginzler, M.D., Professor of Medicine and Chief of Rheumatology at the Downstate Medical Center, State University of New York (SUNY) in Brooklyn. "At Week 52, we saw significant reductions in SLE disease activity as measured by the SELENA SLEDAI and BILAG indices and the Physician's Global Assessment, as well as the patient response rate chosen as the primary efficacy endpoint of the Phase 3 trials. Continued improvements were observed from Week 52 through Week 76 in the 24-week extension phase of the trial."

Dr. Ginzler noted that reductions observed in activated B cells and anti- dsDNA autoantibodies, as well as the improvements observed in health-related quality of life, were associated with therapeutic response. No increase in infections or infectious events was observed over time. "We look forward to continuing the evaluation of LymphoStat-B as a potential treatment for SLE in the Phase 3 trials that are now underway," she said.

Of the patients who completed 52 weeks of treatment in this randomize
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
9. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
10. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
11. Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon
Post Your Comments:
(Date:8/29/2014)... VANCOUVER, British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" ... 2014 fiscal year-end financial statements.  The Company recently changed ... to facilitate an application to list its common stock ... possible. DelMar,s financial statements as filed with ...
(Date:8/29/2014)... , Aug. 29, 2014 ... PHG AEX: PHIA) ... European Society of Cardiology (ESC) Congress ... highlighting the full range of its cardiology solutions serving clinicians ... from prevention and diagnosis, to ...
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... discover technological and commercial prospects What does ... market? Visiongain,s brand new report shows you ...
Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
(Date:8/29/2014)... New York, NY (PRWEB) August 29, 2014 ... industry experienced sparse revenue growth over the ... instability. During the recession, consumers had less disposable ... from grocery stores and visited restaurants less frequently. ... fast food establishments declined, hindering revenue growth. “After ...
(Date:8/29/2014)... 2014 ReputationChief.Com, a well-established online reputation ... Bad Reviews’. This service has been launched to help ... negative reviews against them. , In order to make ... the committed results to its clients, ReputationChief.Com has designed ... of internet marketing. , As per the indications from ...
(Date:8/29/2014)... 2014 Last week, the Fed reported ... monthly gain. Industrial production rose to 0.4% while manufacturing output ... is the single largest boost since February this year. Capacity ... since February as well – an increase that could be ... to a 79.2% rate, which is a measure of slack ...
(Date:8/29/2014)... CPR and basic life support (BLS) videos available ... recent health guidelines, according to a new study ... journal for the Australasian College for Emergency Medicine ... sudden cardiac arrest are known to improve survival ... specialists put together the study, which reviewed educational ...
(Date:8/29/2014)... 29, 2014 As a chiropractic physician ... understands that there’s a direct connection between the condition ... and back. "Since conventional shoe inserts and orthotics weren’t ... of my own," he said. , Customizable to a ... support for the foot in order to help prevent ...
Breaking Medicine News(10 mins):Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:ReputationChief.Com Announces a New Service ‘Remove Bad Reviews’ 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3
... time how our brain,s response changes the closer a ... a volunteer is pursued by an artificial predator, the ... strategic areas of the brain towards more reactive responses ... a threat, such as a large bear, humans, like ...
... In the eyes of mammals, visual information is processed on a ... brain, according to a new report in the August 24 issue ... found in mice that the eyes normal rhythmic response to light ... ticking. The retina is a layer of nerve tissue covering the ...
... in the technology that will drive next generation computers and ... which produces a state that appears to be both on ... simultaneously on and off are vital for the next-generation super ... bits, that are either on or off. , Previously, ...
... study finds , , THURSDAY, Aug. 23 (HealthDay News) -- After ... pre-diabetes rises steeply, a new study finds. , In fact, ... likely to develop diabetes compared with the general population and ... sugar, according to the report in the Aug. 25 issue ...
... reading actually respond better to female teachers, according to ... higher positive self-perceptions as readers when they worked with ... assistants. , The study focused on 175 third- and ... their teachers. The boys participated in a 10-week reading ...
... and bad, experts say , , THURSDAY, Aug. 23 (HealthDay News) ... something, a new study may explain why. , Scientists say ... while a totally separate area is in charge of ... region, involved in an aspect of self-control, may change conceptions ...
Cached Medicine News:Health News:Free will takes flight: how our brains respond to an approaching menace 2Health News:Mouse vision has a rhythm all its own 2Health News:Heart Attack Boosts Diabetes Risk 2Health News:Scientists Spot Brain's 'Free Will' Center 2Health News:Scientists Spot Brain's 'Free Will' Center 3
Designed to minimize emblolic debris in SVGs and carotids...
... therapy extends the ability of interventional ... coronary artery disease, and provides non-interventional ... in the treatment of patients who ... EECP therapy provides a noninvasive, atraumatic ...
... The dual lumen petite titanium ... mm catheter (each lumen) and ... oval lumen catheters offer larger ... catheter strength. Dual lumen offset-tip ...
... The dual lumen M.R.I. model ... 1.2 mm inner diameter catheters ... catheters offer larger lumen equivalency ... ,Dual lumen offset-tip catheters are ...
Medicine Products: